Daniel A.  Carestio net worth and biography

Daniel Carestio Biography and Net Worth

SVP of STERIS
Daniel A. Carestio director since January 2021, and President and CEO since 2021. Prior to that role, he served as Senior Vice President and Chief Operating Officer with responsibility for all STERIS operating businesses from August 2018 to July 2021. He previously served as Senior Vice President, Sterilization and Disinfection from February 2018 to July 31, 2018 and from August 2015 to February 2018 he served as a Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences.

What is Daniel A. Carestio's net worth?

The estimated net worth of Daniel A. Carestio is at least $5.18 million as of May 3rd, 2017. Mr. Carestio owns 25,390 shares of STERIS stock worth more than $5,177,021 as of April 28th. This net worth estimate does not reflect any other assets that Mr. Carestio may own. Additionally, Mr. Carestio receives an annual salary of $1,590,000.00 as SVP at STERIS. Learn More about Daniel A. Carestio's net worth.

How old is Daniel A. Carestio?

Mr. Carestio is currently 51 years old. There are 7 older executives and no younger executives at STERIS. Learn More on Daniel A. Carestio's age.

What is Daniel A. Carestio's salary?

As the SVP of STERIS plc, Mr. Carestio earns $1,590,000.00 per year. Learn More on Daniel A. Carestio's salary.

How do I contact Daniel A. Carestio?

The corporate mailing address for Mr. Carestio and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Daniel A. Carestio's contact information.

Has Daniel A. Carestio been buying or selling shares of STERIS?

Daniel A. Carestio has not been actively trading shares of STERIS within the last three months. Learn More on Daniel A. Carestio's trading history.

Who are STERIS's active insiders?

STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.

Are insiders buying or selling shares of STERIS?

In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.

Information on this page was last updated on 5/15/2023.

Daniel A. Carestio Insider Trading History at STERIS

See Full Table

Daniel A. Carestio Buying and Selling Activity at STERIS

This chart shows Daniel A. Carestio's buying and selling at STERIS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STERIS Company Overview

STERIS logo
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Read More

Today's Range

Now: $203.90
Low: $200.45
High: $204.64

50 Day Range

MA: $221.18
Low: $198.94
High: $236.03

2 Week Range

Now: $203.90
Low: $181.78
High: $254.00

Volume

318,142 shs

Average Volume

558,812 shs

Market Capitalization

$20.15 billion

P/E Ratio

35.71

Dividend Yield

1.03%

Beta

0.79